INTC
Intel
-- 23.600 TSLA
Tesla
-- 355.840 NVDA
NVIDIA
-- 138.850 SOFI
SoFi Technologies
-- 16.210 SMCI
Super Micro Computer
-- 47.910 
(EVAX) Price Target Increased by 414.29% to 18.36
Story by George Maybach •
The average one-year price target for Evaxion Biotech A (NasdaqCM:EVAX) has been revised to 18.36 / share. This is an increase of 414.29% from the prior estimate of 3.57 dated January 16, 2024.
The price target is an average of many targets provided by analysts. The latest targets range from a low of 14.14 to a high of 21.00 / share. The average price target represents an increase of 392.23% from the latest reported closing price of 3.73 / share.
The price target is an average of many targets provided by analysts. The latest targets range from a low of 14.14 to a high of 21.00 / share. The average price target represents an increase of 392.23% from the latest reported closing price of 3.73 / share.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call